Hong Kong Medical Block Chain MCHK” glory set sail

by Health

“Hong Kong Medical Block Chain MCHK” glory set sail

“Hong Kong Medical Block Chain MCHK” participated in the “20th China International Investment and Trade Fair”

1.On September 9, 2018, at the twentieth session of the China International Fair for Investment and Trade, more than 1,000 industrial and commercial groups, about 5,000 companies and more than 120,000 merchants from more than 110 countries and regions gathered in Xiamen .Medisun Medical Group participated in the forum.

The Medisun market team gathered at the Hong Kong medical block chain MCHK at the center booth of Xiajiahui

Terry Lierman (left), Chairman of Medisun Medical Group, and Mr. Danny Wong (right), Executive Chairman, at the “Hong Kong Medical Block Chain” booth

“Hong Kong Medical Block Chain MCHK” hosted the “Blockchain 3.0 Energizing Entity Economic Forum”
Organized by the China Investment Association, Tsinghua x-lab Ivy League Research Institute and Medisun Medical Group’s “Block Chain 3.0 Energizing Entity Economic Forum” became a highlight of the current Xiamen Fair.
Blockchain 3.0 empowers the real economy and has become a new consensus in China’s blockchain industry. Blockchain 3.0 represents the Internet of Things-based blockchain 3.0 technology that truly links the digital economy to the real economy to form a complete blockchain technology, business and financial services ecosystem for the service industry.


Terry Lierman, Chairman of Medisun Medical Group, addressed the investment forum

Mr. Danny Wong (first from right), Chairman of the Medisun Medical Group, signed the strategic cooperation of the “Ticket Reform Laboratory”

Terry Lierman, Chairman of Medisun Medical Group, introduced the Hong Kong medical block chain MCHK

Terry Lierman, Chairman of the American Medical Group, said that the most critical factors in the health care system are Transparecny, Quality and Access. The reason why the US medical system does not have such an accident in China is because the US FDA adheres to the standard approval and monitoring process for medical products. This is the effectiveness of the medical system. The Hong Kong medical blockchain will also be reliable. The medical platform is based on blockchain technology. Any vaccine products and medical products are produced, circulated and used on the MCHK platform are transparent and traceable.

“Hong Kong Medical Chain Chain MCHK”, as the Hong Kong medical service public chain, is based on the collection of 500 advanced medical institutions in Hong Kong. It integrates 5,000 medical institutions in the Greater Bay Area within three years, and uses the blockchain technology as a framework to integrate Medisun Medical The Group’s rich clinical research and development technology and experience in regenerative Medisun have enhanced the trust and consensus of the children’s vaccine and cancer vaccine industry, promoted the integration and upgrading of the medical industry in Dawan District, and achieved the first to meet the international standard level in the “9+2 City” medical service system in Dawan District.

“Hong Kong Medical Block Chain MCHK” won the “Blockchain Innovation Enterprise Award”

This forum held the awarding ceremony of “Blockchain 3.0 Encouraging Entity Economy Top Ten Innovative Enterprises”. “Hong Kong Medical Block Chain MCHK” won the award as the latest medical health platform based on blockchain technology.

Mr. Danny Wong (third from left), Executive Chairman of Medisun Medical Group, received the award.

Launching Ceremony of “Hong Kong Medical Blockchain MCHK”

On September 10th, the launching ceremony of the Hong Kong medical block chain MCHK was held in Xiamen. The chairman of the group, Terry Lierman, and the executive chairman of the group, Mr. Danny Wong, co-chaired and opened the champagne. The marketing team raised a toast to celebrate this memorable day!

Hong Kong Medical Block Chain MCHK Launch Ceremony

MCHK “Hong Kong Medical Block Chain” Hong Kong Medical Services Public Link is a joint venture of Medisun Medical Group.

Headquartered in Hong Kong, Medisun Medical Group is a professional medical investment group dedicated to the research and development and commercialization of global regenerative product technology, as well as quality hospitals and treatment centers. Medisun has long-term cooperation with the Johns Hopkins Life Science Center and the Harvard University Stem Cell Institute, working on the investment and research and development of new technologies in the field of regenerative worldwide, and conducting clinical trials in many well-known hospitals in mainland China and Hong Kong; In cooperation with Tsinghua University, Medisun established the “Medical Institute of Cell Technology of Tsinghua University” and “Medical University Tsinghua University Regenerative Medisun Industry Fund”.

The Medisun Regenerative Centre is located in Kowloon Bay, Hong Kong. It has an international GMP standard medical laboratory, cancer treatment center and anti-aging center. It provides immune cell therapy, a variety of stem cell health treatments, a number of child and adult vaccinations and a full range of biomedical products. Testing to provide customers with the most predictable health protection.

For more information, please visit http://www.medisun.hk/

Hair transplant in Turkey for spanish citizens

by Health

Patients should wait a minimum of 48 hours before washing their hair unless otherwise advised by their physician. After that, they can slowly start washing their hair with shampoo and warm water, using lukewarm water to rinse. This method should be followed during the first 14 days after the procedure to prevent excessive scabbing. After that, with the advisory of their physician, the patient should be able to resume normal hair washing habits but with caution. Grooming after hair transplantation should be done very cautiously and carefully.

What is a hair transplant? A hair transplant is a procedure in which a plastic or dermatological surgeon moves hair to a bald area of the head. The surgeon usually moves hair from the back or side of the head to the front or top of the head. Hair transplants typically occur in a medical office under local anesthesia. Pattern baldness is responsible for the majority of hair loss. This comes down to genetics. The remaining cases are due to a variety of factors, including: diet, stress, illness, hormonal imbalance, medications. Are there different types of hair transplants? There are two types of transplant procedures: slit grafts and micrografts. Slit grafts contain 4 to 10 hairs per graft. Micrografts contain 1 to 2 hairs per graft, depending on the amount of coverage needed. Who might benefit from a hair transplant? Receiving a hair transplant can improve your appearance and self-confidence. Good candidates for a hair transplant include: men with male pattern baldness, women with thinning hair, anyone who has lost some hair from a burn or scalp injury. Hair replacement isn’t a good option for: women with a widespread pattern of hair loss throughout the scalp, people who don’t have enough “donor” hair sites from which to remove hair for transplant, people who form keloid scars (thick, fibrous scars) after injury or surgery, people whose hair loss is due to medication such as chemotherapy. What happens during a hair transplant? After thoroughly cleaning your scalp, a surgeon uses a small needle to numb an area of your head with local anesthesia. Two main techniques are used to obtain follicles for transplantation: FUT and FUE. In follicular unit transplantation (FUT): The surgeon will use a scalpel to cut out a strip of scalp skin from the back of the head. The incision is typically several inches long. This is then closed with stitches. The surgeon next separates the removed portion of scalp into small sections using a magnifying lens and sharp surgical knife. When implanted, these sections will help achieve natural-looking hair growth. In follicular unit extraction (FUE) the hair follicles are cut out directly from the back of the head through hundreds to thousands of tiny punch incisions. The surgeon makes tiny holes with a blade or needle in the area of your scalp that’s receiving the hair transplant. They gently place hairs in these holes. During one treatment session, a surgeon may transplant hundreds or even thousands of hairs. After, the graft, gauze, or bandages will cover your scalp for a few days. A hair transplant session can take four hours or more. Your stitches will be removed about 10 days after surgery.

Why hair transplant? Traction alopecia, This type of hair loss occurs due to exertion of external pressure on the hair which may cause it to fall. If the hair does not grow back then it would result in a bald patch. Thus you may opt for a hair transplant procedure if you suffer from this disorder and experience loss of hair.

Alternatives Hairpieces: These offer a non-surgical means of restoring hair by covering bald areas of the scalp.There is a large variety of means for attaching these. The most common are glue adhesives, “weave” attachments, and clips.

Before surgery your hair should be washed twice a day, two times well. But be careful not to follow the process of hair spa before surgery. A week before hair transplant you should not take hard drugs or any kind of antibiotics and aspirin But of you are undergoing treatment for a serious illness, this should consult the doctor about the course.

Keep the head in elevated position by using several pillows under the neck while sleeping. This decreases swelling and also reduces the chance of developing any damage to the transplanted hair. Some drugs help in reducing the incidence of swelling but these drugs should be taken according to the prescription of a doctor. Some anti-inflammatory drugs also act on swellings other than their action as analgesic.

More info on Trasplante Capilar Turquia. DHI, which stands for DIRECT HAIR IMPLANTATION, is a new technique in hair transplantation through which hair follicles are implanted one by one directly to the rare or bald area of the head that needs to be covered. Each hair follicle is planted in a specific direction, angle, and depth so that the patients will have totally natural outlook and maximum viability and visibility with no scars at all. The implanted hairs continue to grow throughout a patient’s lifetime and never fall out. Compared to the outdated FUT (Follicular Unit Transplant) and FUE (Follicular Unit Extraction) methods, the DHI hair transplant technique has many benefits and superiorities. First and foremost, procedures are done by a DHI certified doctor, not technicians and nurses. Secondly, less donor hairs are needed. This is important because only the surviving hair is worth paying for. Through the operation no scalpels and stitches applied and for this reason there will be virtually no scarring.

基金成立

The launch of Qingkong Crossing Digital Industry Fund

by Health

Qingkong Crossing Digital Industry Fund Launched.

Blockchain 3.0 votes change consensus unveiled at 9.8 CIFIT

On September 9th, the 20th China International Investment and Trade Fair – 2018 blockchain technology enabling entity economic investment forum was held in Xiamen, this forum was hosted by China Investment Association Investment Advisory Committee, Tsinghua x-lab Ivy The Chain Alliance Research Institute and the Shun Tak T30 Parent Fund jointly hosted.
Chairman of the China Investment Association Investment Advisory Committee, Mr. Huiye Zhu, Secretary General of the China Electronic Chamber of Commerce Blockchain Special Committee Mr. Li Yinke, the president of Tsinghua x-lab lvy Chain Research Institute, Mr. Zhong Hong, Partner of the Crossing Fund, Mr. Terry Lehman and Mr. Danny Wong, Co-founders of Medivh Medical Group, Mr. Chen Jianren, Chairman of the Board of Directors of Xiaobawang Group, Mr. Yang Yun, Chairman of Board of Directors of Hong Kong Dachang Financial Technology Group, Jinhaohao Technology Holdings Mr. Jin Qiu Bing, co-founder of the group, Mr. Li Shuai, CEO of Core Cartoon Technology, and Mr. Li Hongkun, President of Diplo Continental Technology, attended the forum,the scale of this year’s Xiamen meeting is huge. More than 1,000 industrial and commercial groups, more than 5,000 companies and more than 120,000 merchants from more than 110 countries and regions gathered in Xiamen. This forum has become a highlight of this year’s Xiamen Fair. The “Qingdao Crossing Digital Industry Fund and Blockchain 3.0 Energizing Entity Economy Baicheng Baihui Project” jointly initiated by Tsinghua x-lab Qingteng Chain Research Institute, Qingkong Crossing Fund and Shunde Fund, officially launched, the future It will cooperate with 100 cities and 100 industry chambers of commerce to develop blockchain 3.0 to enable the real economy lecture hall, and find successful cases of blockchain technology application in the industry.

The forum also carried out the ceremony of “Strategic Cooperation Signing of Block Chain 3.0 vote change Laboratory” and the awarding ceremony of “Top 10 Innovative Enterprises in Block Chain Energizing Entity Economy”. The award-winning enterprises included Xiao bawang Ruyi Culture Technology Co., Ltd. (BWTT), Hong Kong Medici Medical Holding Group (MCHK), Hong Kong Dachang Financial Technology Co., Ltd. (BMY), Jinhaohao Technology Holdings (DJMT), Core Cartoon Technology (SWWT), Hong Kong Zangjintang Biotechnology ( TOT) Tiebao Continental Technology (TBB), Property Chain Technology (TCT), Shunde Parent Fund (T30), and Good Skin Biotechnology Co., Ltd. (DST).

In the speech, the Chairman of the China Investment Association’s Investment Advisory Committee, Mr. Zhu Huizhen, said that the blockchain technology itself can promote the development of the real economy. We support new technologies to bring new kinetic energy to the economy, and we hope that more entities can Participate in the practice of this blockchain 3.0 ticket reform, and make more successful cases of blockchain empowerment of the real economy.

Li Yinke, secretary general of the China Electronics Chamber of Commerce Blockchain Committee of the Ministry of Industry and Information Technology, said in his speech that the blockchain as a bottom layer technology has already made successful industrial applications in certain areas of financial technology. Core cartoon is a good example. Hope In the future, relying on the power of the Chamber of Commerce to promote more blockchain technology companies to empower the real economy.

In the theme sharing, the president of Qinghua x-lab, has proposed a blockchain 3.0 to empower the real economy, which has become a new consensus in China’s blockchain industry. Blockchain 3.0 represents the IoT-based blockchain 3.0 technology that truly links the digital economy to the real economy to form a complete blockchain technology, business and financial services ecosystem for the service industry.

The blockchain 3.0 vote change laboratory is an innovative experimental platform that promotes the blockchain 3.0 to empower the real economy. It will integrate experts in seven fields of politics, production, learning, research, investment, innovation and media to form a national ministry. The local government and industry think tanks aim to promote the transformation and upgrading of China’s current real economy, and jointly promote the research and implementation plan of the blockchain 3.0 industry vote change theory and the implementation of the blockchain industry service organization. The real economy enterprises are fully docked, and a complete vote change plan will be formed before the end of 2018, and the first batch of vote change pilot zones will be built in the country with various industry associations. 基金成立

Qingkong Daokou Digital Industry Fund & Blockchain Empowerment Entity Economy Baicheng Baihui Launched.

The president of Shun Tak T30, the co-founder of the vote change lab, Hu Jiesen, made a wonderful topic sharing in the forum. He said that the essence of blockchain technology is to solve the problem of trust and consensus.

“Qingkong Daokou Digital Industry Fund”, relying on the technology and financial resources of Tsinghua Holdings and Tsinghua Wudaokou Finance College, will focus on using the power of technology and capital to help “blockchain vote change laboratory” and establish blockchain empowerment The real economy innovation ecology. The ticket-changing public chain “chain ticket” project currently being hatched is supported by the blockchain 3.0 underlying public chain technology, which will serve the assets of the entity, and relieve the inventory backlog and financing difficulties in the form of digital tickets. The problems faced by the entity enterprises, the current property chain ticket project has been applied in the medical and insurance industry. In the 2018, when the real economy encountered major challenges, the “blockchain 3.0 vote change laboratory” is incubating a batch of industry application success stories. And will rely on the strength of domestic industry associations and local governments to jointly empower the real economy. 票改

vote change lab launching ceremony

颁奖

大合影

合影

Group photo of some guests at the meeting

For more information, please visit http://www.medisun.hk/

Medical benefits of cannabis

by Health

Benefits ? It Fights Cancer: This is the big one that everybodys been talking about. Both scientists and the federal government have released a good amount of evidence showing that cannabinoids fight certain types of cancer. It doesnt get much more substantial than that.

PMS and Menopause Symptoms: The gamma-linoleic acid contained in these seeds is known for reducing the effects of a hormone known as prolactin. The hormone prolactin is associated with the physical and emotional symptoms of premenstrual syndrome and menopause. These seeds can help to reduce symptoms during these times.

Helps to Prevent Cancer: Cannabis is said to promote good general health and has been found to help in the prevention of tumours and various forms of cancer. According to some studies, using cannabis seeds will reduce the risk of developing colon and intestinal cancers. The medicinal properties of the seeds make it a great substance for relieving pain during chemotherapy.
With the wide array of benefits cannabis seeds can have on the body, its clear to see that their use in medicine should be considered and used.

Medical Conditions and the Benefits of Cannabis

Medical Condition -> Benefits of Cannabis
Diabetes -> Lowers blood sugar for very short periods
Asthma -> Reduces spasms and relaxes the bronchial muscles
Crohn’s Disease -> Reduces abdominal cramps, controls bowel movement, reduces pain and improves appetite
Migraine -> Pail relief, helps with relaxation, stops sickness and aids sleep
Parkinson’s Disease -> Relaxes the muscles and reduces tremors. Can also reduce the side effects of conventional medicines
Epilepsy -> Decreases the number of seizures
Stress & Tension -> Removes anxiety and reduces the blood pressure
Arthritis -> Reduces pain, relaxes muscles which allows greater mobility
Multiple Sclerosis -> Reduces muscle stiffness and spasms. Pain and nerve relief. Helps improve muscle co-ordination

CBD and Medical Cannabis Research

CBD can be used therapeutically as an analgesic, anti-anxiety, anti-bacterial, anti-cancerous, anti-convulsive, anti-depressant, anti-emetic, anti-inflammatory, anti-ischemic, anti-psychotic, anti-spasmotic, bone stimulating, immunosuppressive, and neuroprotective medicine. More info at High CBD Seeds UK

Cannabis and the Law

Cannabis legislation is being relaxed all over the world but not in the UK, where the most unlikely of horticulturalists are taking the law into their own hands At Discount Cannabis Seeds we only sell Cannabis Seeds as souvenirs and we do not accept any liability for customers purchasing them for any other purposes.

Is Cannabis legal?

Cannabis, unfortunately does not follow a strict line of being legal or illegal across the globe, and in fact can vary considerably in each country depending on its use and form.
Whilst it is illegal to own or possess the drug in the vast majority of countries around the world, many countries have in fact decriminalised possession in small quantities, with the reasoning that it isn’t being used to sell or supply.
In the UK, it is actually LEGAL to own cannabis seeds, such as the ones available on the Discount Cannabis Seeds website, but it is 100% ILLEGAL to grow or attempt to grow the cannabis plant from these seeds unless you have a licence from the Home Office.
WE STRICTLY ADVISE THAT PURCHASED CANNABIS SEEDS ARE NOT USED TO GROW CANNABIS PLANTS AS THIS PRACTICE IS ILLEGAL WITHOUT A LICENCE.

Is is well known, certain countries permit the possession of cannabis in certain circumstances, such as the Netherlands and Uruguay. More recently, a number of states in the USA have enacted legalisation of the plant.

We deal with the most reputable Seed Banks from around the world, many of which have their own quality control procedures which include testing the germination rates.

Legal Access to Cannabis in the UK

Access to cannabis within the UK is limited to the pharmaceutical cannabis based medicine Sativex.

Sativex is an oromucosal spray of a formulated extract of the Sativa cannabis plant that contains the principal cannabinoids THC and CBD as well as specific minor cannabinoids and other non-cannabinoid components.

This can only be prescribed to MS sufferers and is at your doctors discretion, so differing postcodes can effect access.

It should also be noted that although the NHS in Wales will subsidise Sativex, the NHS in England will not, so typical treatments can cost up to 500 a month.

All other cannabis use or production in the UK is Illegal.

Medisun launched the “Hong Kong Regenerative Medisun Association”

by Health

Medisun launched the “Hong Kong Regenerative Medisun Association”

On May 28, 2018, the Hong Kong Regenerative Medisun Association, which was initiated by representatives from the Hong Kong Regenerative Medisun Industry and academic circles, was formally established under the auspices of the Medisun Medical Group.

Hong Kong Regenerative Medisun Association goals

The Hong Kong Regenerative Medisun Association was founded by experts, scholars, industry representatives and people of insight in the field of regenerative Medisun in Hong Kong and around the world. The purpose of the association is to establish a consensus platform for the regenerative Medisun industry in Hong Kong, promote the development of the regenerative Medisun industry, encourage and promote international cooperation, and propose to the Hong Kong SAR government the recommendations of the regenerative Medisun industry on industry regulations and actively influence industry rules. The establishment and improvement of the company provides effective technical and management advice to the Hong Kong government, Hong Kong public health agencies and companies in the industry.

The first meeting of the Hong Kong Regenerative Medisun Association (May 28, 2018)

On the afternoon of May 28, representatives from Hong Kong’s medical health, regenerative Medisun and biotechnology fields, doctors, pharmacists, chemists and university researchers gathered to discuss and elect the first council of the Hong Kong Regenerative Medisun Association.They read the charter of the association and clarify the duties of the board. At the same time, they have had a heated discussion on the regulatory documents issued by the Hong Kong SAR Government on Advanced Therapy Products. They agreed to regulate the direction of document guidance and proposed a number of issues that need to be clarified, including:

1. Professional qualifications required by the licensee of the Regenerative Medisun and Stem Cell Research and Development Organization;

2. Advanced Therapy Products is regulated by the Pharmacy and Poisons Ordinance (Cap. 138). However, since the production process and user definition of cellular products and pharmaceutical products are different, they should be clarified accordingly;

3. With reference to the requirements of the international GMP/PICS standard, which standard should be achieved in the cell laboratory qualification of existing regenerative Medisun institutions;

4. After the specific regulation is in force, whether there should be a transition period, so that the industry has time to adjust and cooperate;

5. Submit the Advanced Therapy Products comments and submit them to the Hong Kong Department of Health.

Member of the First Council of the Hong Kong Regenerative Medisun Association

Position

Name

 Qualifications

Chairman

Danny Wong Mr. Wang Xiaofeng

 Founder and Chairman of Medisun Medical Group, years of investment experience in the field of regenerative Medisun, understanding the development and trends of the biotechnology industry

Vice President

Joseph Wang  Dr. Wang Qiyuan

Registered as a doctor, founder of the Hong Kong Stem Cell Center, enriching the clinical experience of regenerative Medisun

Vice President

David Leung Mr. Liang Yaoming

Registered pharmacist, familiar with pharmaceutical regulations and GMP requirements

Vice Chairman

Gregory Cheng Professor Zheng Yanming

Hematology expert, Professor of the University of Macau Health Sciences

Director | Treasurer

Kenneth Lee Dr. Li Zhisheng

Registered as a doctor, B Q Anti-aging Center Consultant

Director

Philip Choy Dr. Cai Shaolong

Ph.D. in Natural Medisun, Madison Biomedical Director

Director

Daniel Tam Dr. Tan Yizhu

Registered as a medical laboratory technologist, director of the Trans-Olympic Blood Bank Laboratory, focusing on cell culture technology for many years

Director

Vivien Leung Ms. Liang Yiqun

 Registered as a medical laboratory technologist, manager of the Trans-Olympic Blood Bank Laboratory, familiar with quality management

Director

Chris Wong Dr. Huang Libao

 Registered as a medical laboratory technologist, director of HKMDPC, molecular biodiagnostic expert

Secretary

Sidney Tam Dr. Tan Guozhen

Chief Executive Officer, Life Clinic, Health Management Consultant

Secretary

Allen Chan Mr. Chen Yuxin

Registered as a medical laboratory technologist, familiar with quality management

The first meeting of the Hong Kong Regenerative Medisun Association (May 28, 2018)

Hong Kong Regenerative Medisun Association’s recent work plan

Next, the Hong Kong Regenerative Medisun Association will issue letters to the organizations including the Hong Kong Department of Health, the Hong Kong Stock Exchange, the Hong Kong University Biomedical Science, Life Sciences, and the Global Regenerative Medisun Alliance (ARM). include:

1. Announced the official establishment of the Hong Kong Regenerative Medisun Association

2. Announce the initial membership list of the Hong Kong Regenerative Medisun Council, association charter, association vision and goals

3. Call for the support and participation of experts, scholars and industry representatives from Hong Kong and around the world

4. Propose to the Hong Kong Government to clarify regulatory regulations on Advanced Medisun and Advanced Therapy Products

Special thanks

Thank you for taking the time to attend the representatives of the institutions, including:

Medisun Medical Group | Medisun Reproductive Medisun Center

Hong Kong Life Science and Technology Group Co., Ltd.

Standard Pathology Laboratory Co., Ltd.

BIH

Living Tissues company limited

BIB Health Care Centre

Hongxin Medical Center

Austa beauty

Hong Kong International Regenerative Medisun Centre

HKMPDC

Huixin Technology

Guangzhou Biological Institute

Trans-along cord blood bank

Hong Kong Stem Cell Center

Life Length

Biocell

Cordlife

For more information, please visit http://www.medisun.hk/

Steam cells treatment of Cartilage and Osteoarthritis

by Health

Articular cartilage degeneration such as osteoarthritis is one of the most common causes of chronic pain, stiffness, and loss of joint movement in middle-aged and older population. The repair of the damaged cartilage using autologous chondrocytes is often compromised by their limited capacity for proliferation and the rapid loss of phenotype during ex vivo expansion. Alternatively, stem cells may be a promising cell source because of their high proliferation rate and ability to differentiate into chondrocytes. An effective differentiation platform is needed, however, to ensure the promise of stem cells for cartilage regeneration.

Profectus Biotech and Medisun Medical Group new joint venture in Hong Kong

by Health

The famous American vaccine company Profectus settled in Hong Kong

First recommend HPV cervical cancer treatment vaccine

BALTIMORE, MARYLAND, USA and HONG KONG, April 20, 2018

Profectus Biotech and Medisun Medical Group today announced the opening of a new joint venture in Hong Kong. The primary mission of the new company, ProMed BioSciences, Ltd., is to establish a leading vaccine company focused on the development of preventive and therapeutic vaccines for infectious diseases and cancer. The joint venture will leverage Profectus’ vaccine development expertise, clinically proven vaccine platform technology and a developing vaccine product line, in line with Medisun’s expertise, established clinical network and market access capabilities, expected in the second half of 2018 to put into operation.

The company’s first product development program will focus on the development, production and commercial application of prophylactic and therapeutic vaccines for HPV (human papillomavirus)-related lesions and cervical cancer [based on PBSVax® technology developed by Profectus]. ProMed BioSciences also plans to develop and treat hepatitis C virus (HCV), hepatitis B virus (HBV), herpes simplex virus (HSV), respiratory syncytial virus (RSV), and human immunodeficiency virus (HIV). Chikungunya and Zika, as well as personalized vaccines to treat cancer. The joint venture is expected to launch new vaccines in their respective markets, which will help promote the development of new vaccines, but ultimately the goal is to benefit patients around the world.

Mr. Jeffery Meshulam (first from left), President of Profectus Biotechnology, Mr. Terry Lierman (second from left), Chairman of Medivh Medical Group, and Mr. Danny Wong (fourth from right), founder and executive chairman of Medisun Medical Group, at Profectus ,USA.

– Long-term strategic cooperation to address the huge demand for prevention and treatment of infectious diseases and cancer in Asia

-Profectus’ expertise in vaccine development and platform technology, combined with Medisun’s localized expertise and experience, to establish a leading Hong Kong vaccine company focused on serving Asia

“This strategic cooperation will help establish Profectus’ business in Hong Kong and China. Through close cooperation with Medisun, we can assist Hong Kong and China to develop advanced vaccine technology to help prevent and treat Asian patients. Mr. Jeffrey Meshulam, President of Profectus, said, “We are pleased to be able to work with recognized local partners to achieve the highest standards of scientific research and development integration and medical services.”

“This collaboration will help Profectus and Medisun to jointly produce life-saving vaccines for infectious diseases and cancer, and address the huge medical needs that have not been met in Hong Kong, China and Asia.” Mr. Danny Wong, founder and executive chairman of Medisun Medical Group, said “ProMed BioSciences will leverage Profectus’ expertise in vaccine development and technology, combined with Medisun’s local expertise and close links with healthcare facilities in Hong Kong and China, and government medical regulatory agencies to develop vaccines to provide leadership for Asian patients disease prevention and treatment programs.”

ProMed BioSciences will focus on the following:

• Conduct technical research in Hong Kong or China

• Conduct clinical trials in Hong Kong or China

• Promote the expansion of Medisun Medical Center

• Develop vaccines to address disease prevention needs

• leverage to maximize the expertise of both partners

Mr. Jeffery Meshulam, President of Profectus Biotechnology (first from left), Mr. Terry Lierman, Chairman of Medisun Medical Group (first from right), Mr. Danny Wong, founder and executive chairman of Medisun Medical Group (middle), at the US headquarters of  Profectus.

About ProMed BioSciences

ProMed BioSciences Limited is a joint venture between Profectus BioSciences (USA) and Medisun Medical Group (Hong Kong) in Hong Kong to develop and conduct new vaccine clinical trials and commercial applications to address infectious diseases and cancer in Asia with the huge demand for prevention and treatment.

About Medisun

Headquartered in Hong Kong, Medisun Medical Group is a professional medical investment group dedicated to the research and development and commercialization of global regenerative Medisunne products, as well as quality hospitals and treatment centers. Medisun invests extensively in the fields of regenerative and stem cell patent technology, including stem cell therapy for heart failure, stem cell therapy for liver disease, kidney disease, nervous system disease, cancer, AIDS, and immune cell therapy for a variety of cancers. Medisun and Harvard University Stem Cell Research Institute, Johns Hopkins Medical School Life Science Center, Tsinghua University and other institutions have long-term cooperation plans to jointly invest in regenerative and stem cell therapy technology, with Medisun as a cooperative business The holding entity and holds global intellectual property rights. Medisun and the University of Maryland’s Institute of Human Virology (IHV) set up a technology clinical trial and development platform for viruses and cancer. Based on the Medisun Biomedical Laboratory in Hong Kong, Radiation will jointly build medical clinics in China and Asia. The experimental resource network promotes the world’s largest clinical research and development platform for virus research and cancer treatment technology. The Medisun Reproductive Centre is located at the Proud Square in Kowloon Bay, Hong Kong. It has a 50,000 square foot stem cell GMP production base, a cancer treatment centre and an anti-aging centre. It brings together European, Japanese, American and individual Chinese experts to develop a rigorous and professional R&D process. Provides immune cell therapy and a variety of stem cell health treatments.

For more information, please visit http://www.medisun.hk/

About Profectus BioSciences

Profectus BioSciences is a clinical stage vaccine development company focused on developing new vaccines for infectious disease and cancer prevention and treatment. The Profectus vaccine is based primarily on the company’s proprietary VesiculoVax™ and DNA vaccine technology platform. By simply using the VesiculoVax™ vaccine alone, B cells can be rapidly expanded to provide protection against emerging infectious diseases that threaten public health and biodefense mechanisms, such as Ebola, Marburg, Chikungunya, Zika virus, equine encephalitis virus, and respiratory syncytial virus. When VesiculoVax™ is used as a vaccine when the immune system is launched with the best pDNA vaccine, the Vesiculo Vax™-directed vaccine expands the triggered T cells into effector cells, which are ideal for attacking virus-infected cells and cancer. Current projects using the Prime / Boost Vaccine System (PBS Vax™) strategy include hepatitis B virus (HBV), human papillomavirus (HPV), herpes simplex virus type 2 (HSV-2) and human immunodeficiency virus ( HIV). Partners and collaborators include UTMB’s Galveston National Laboratory, Yale University, University of Maryland Human Virology Institute, HIV/AIDS Vaccine Immunology Center, National Cancer Institute, National Institutes of Health AIDS Division, Bill And the Melinda Gates Foundation, the International AIDS Vaccine Initiative, the AIDS Vaccine Trial Network and the AIDS Clinical Trial Group. Profectus is funded by Cross Atlantic Capital Partners (“XACP”) in Radnor, Pennsylvania. The main investor in XACP is the Pennsylvania Public School Employees Retirement System (“PSERS”). For more information, please visit www.profectusbiosciences.com

Regular health screening is important for your health

by Health

There are a number of possible approaches to health checks (e.g. individual appointments or drop-in sessions). Organisations should choose the best option for them based on a number of factors, e.g. the size of the organisation, cost implications, the type of business and the pattern of work of employees. Individual appointments allow time for a comprehensive range of checks and tests to be carried out (e.g. cholesterol testing, BMI, blood glucose levels, blood pressure tests, etc.) and the chance for an employee to sit down in private and talk through the results with a trained professional. Drop-in sessions are quick and easy to arrange and less expensive for the employer than individual appointments. Each member of staff would be allocated a brief slot during which some basic tests could be carried out (e.g. BMI and blood pressure checks).

When and how often you get screening tests may depend on your age, your gender, your health status, and your risk factors. Your doctor may suggest screening tests based on expert guidelines. In some cases, testing is done as part of a routine checkup. When you are thinking about getting a screening test, talk with your doctor. Find out about the disease, what the test is like, and how the test may help you or hurt you. You may also want to ask what further testing and follow-up will be needed if a screening test result shows a possible problem.

Who Carries Out The Screening? Such assessment tests are done by the doctor or a health expert at a private hospital, who begins by filling your necessary details like the BMI, height, and weight. Later, the doctor will have a conversation with you about the lifestyle you have, daily activities, if you smoke or not, if you drink, eating habits, among others.

For more info about health screening clinics in London : find out more. Once your health screening results are back the doctor will prescribe the appropriate medication or treatment for your requirements. Health screening in London is available to all genders and age ranges.

There are many benefits that accrue to the individual person after undergoing a health screening such as: Reduced health risks – The test will bring out any problem which will then be addressed in the best way possible. It might be an early signal for diabetes or any other kind of problem which can be addressed early. If it is an advanced case then proper remedies can be carried out.

The benefits that an organisation gets from having a health screening arrangement cannot be enumerated. Its workforce is so important that it makes a lot of sense to have ways and methods of detecting early sickness in employees. Some of the benefits are: Absence due to sickness reduced – Absence due to illness is something that every sensible manager should dread. This kind of absence is not planned and hence it causes a lot of disorganisation in an institution.